| |
| |
|
| Insider
Information: |
Gardiner Nathaniel S. |
| Relationship: |
Chief Legal Officer |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
75,688 |
|
|
Indirect Shares
|
35,926 |
|
|
| Direct
Value |
$988,485 |
|
|
|
Indirect Value
|
$469,194 |
|
|
| Total
Shares |
111,614 |
|
|
| Total
Value |
$1,457,679 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 36.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Chief Legal Officer |
2024-02-26 |
75,688 |
2024-02-26 |
35,926 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2015-02-13 |
4 |
B |
$33.00 |
$13,200 |
D/D |
400 |
400 |
2.74 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2015-02-17 |
4 |
B |
$33.10 |
$33,322 |
D/D |
1,000 |
1,400 |
2.74 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2016-05-11 |
4 |
B |
$24.45 |
$12,223 |
D/D |
500 |
1,900 |
2.74 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,200 |
4,100 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2017-02-13 |
4 |
D |
$29.82 |
$24,746 |
D/D |
(830) |
3,270 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2018-02-08 |
4 |
OE |
$34.70 |
$149,210 |
D/D |
4,300 |
7,570 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2018-02-12 |
4 |
D |
$76.85 |
$158,685 |
D/D |
(2,065) |
12,327 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,822 |
14,392 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2018-10-01 |
4 |
OE |
$34.70 |
$52,050 |
D/D |
1,500 |
13,827 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2018-12-06 |
4 |
OE |
$34.70 |
$69,400 |
D/D |
2,000 |
15,827 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-01-22 |
4 |
OE |
$34.70 |
$69,400 |
D/D |
2,000 |
17,827 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-02-12 |
4 |
D |
$88.88 |
$406,982 |
D/D |
(4,579) |
27,248 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
31,827 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-02-13 |
4 |
AS |
$95.28 |
$311,562 |
D/D |
(3,270) |
23,978 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-03-06 |
4 |
OE |
$31.42 |
$84,802 |
D/D |
2,519 |
26,497 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-06-26 |
4 |
OE |
$31.42 |
$103,529 |
D/D |
3,295 |
14,871 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-06-26 |
4/A |
OE |
$31.42 |
$103,529 |
D/D |
3,295 |
13,147 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-09-27 |
4 |
OE |
$30.00 |
$150,000 |
D/D |
5,000 |
19,871 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-11-22 |
4 |
OE |
$31.42 |
$50,021 |
D/D |
1,592 |
19,739 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
24,989 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2019-12-16 |
4 |
D |
$63.88 |
$148,904 |
D/D |
(2,331) |
22,658 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-02-12 |
4 |
D |
$52.76 |
$49,594 |
D/D |
(940) |
24,605 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,887 |
25,545 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-03-12 |
4 |
OE |
$30.00 |
$90,000 |
D/D |
3,000 |
27,605 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & General Counsel |
• – – |
2020-08-05 |
4 |
OE |
$30.00 |
$49,980 |
D/D |
1,666 |
29,271 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
